APO Research
Talk to an analyst

APO RESEARCH · REPORT

Matrine for Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Matrine for Injection Market Analysis and Forecast 2026-2032

30 December 2025198 pages

Choose your research edition.

Industry ResearchMatrine for Injection Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Matrine for Injection Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Matrine for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Matrine for Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Matrine for Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Matrine for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Matrine for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Matrine for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Matrine for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Matrine for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Matrine for Injection include Chengdu Tiantai Mount Pharmaceutical, Henan Rongcheng Pharmaceutical, Jiuquan Dadeli Pharmaceutical, Nirvana Pharmaceutical, Trifecta Pharma Co. Ltd and CTTQ PHARMA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Matrine for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Matrine for Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Matrine for Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Matrine for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Matrine for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Matrine for Injection sales, projected growth trends, production technology, application and end-user industry.

Matrine for Injection Segment by Company

Chengdu Tiantai Mount Pharmaceutical

Henan Rongcheng Pharmaceutical

Jiuquan Dadeli Pharmaceutical

Nirvana Pharmaceutical

Trifecta Pharma Co. Ltd

CTTQ PHARMA

Matrine for Injection Segment by Type

Intramuscular Injection

Intravenous Drip

Matrine for Injection Segment by Application

Chronic Hepatitis B Treatment

Tumor Radiotherapy

Others

Matrine for Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Matrine for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Matrine for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Matrine for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Matrine for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Matrine for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Matrine for Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Matrine for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Intramuscular Injection Major Manufacturers Table 3. Intravenous Drip Major Manufacturers Table 4. Global Matrine for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Chronic Hepatitis B Treatment Major Manufacturers Table 6. Tumor Radiotherapy Major Manufacturers Table 7. Others Major Manufacturers Table 8. Matrine for Injection Industry Trends Table 9. Matrine for Injection Industry Drivers Table 10. Matrine for Injection Industry Opportunities and Challenges Table 11. Matrine for Injection Industry Restraints Table 12. Global Matrine for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Matrine for Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Matrine for Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Matrine for Injection Revenue Market Share by Region (2021-2026) Table 16. Global Matrine for Injection Revenue Market Share by Region (2027-2032) Table 17. Global Matrine for Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Matrine for Injection Sales by Region (2021-2026) & (K Units) Table 19. Global Matrine for Injection Sales by Region (2027-2032) & (K Units) Table 20. Global Matrine for Injection Sales Market Share by Region (2021-2026) Table 21. Global Matrine for Injection Sales Market Share by Region (2027-2032) Table 22. Global Matrine for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Matrine for Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Matrine for Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Matrine for Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Matrine for Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Matrine for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Matrine for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Matrine for Injection Manufacturers, Product Type & Application Table 30. Global Matrine for Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Matrine for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Matrine for Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Matrine for Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Matrine for Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Matrine for Injection Revenue Market Share by Type (2021-2026) Table 37. Global Matrine for Injection Revenue Market Share by Type (2027-2032) Table 38. Global Matrine for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Matrine for Injection Sales by Type (2021-2026) & (K Units) Table 40. Global Matrine for Injection Sales by Type (2027-2032) & (K Units) Table 41. Global Matrine for Injection Sales Market Share by Type (2021-2026) Table 42. Global Matrine for Injection Sales Market Share by Type (2027-2032) Table 43. Global Matrine for Injection Price by Type (2021-2026) & (US$/Unit) Table 44. Global Matrine for Injection Price by Type (2027-2032) & (US$/Unit) Table 45. Global Matrine for Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Matrine for Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Matrine for Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Matrine for Injection Revenue Market Share by Application (2021-2026) Table 49. Global Matrine for Injection Revenue Market Share by Application (2027-2032) Table 50. Global Matrine for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Matrine for Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Matrine for Injection Sales by Application (2027-2032) & (K Units) Table 53. Global Matrine for Injection Sales Market Share by Application (2021-2026) Table 54. Global Matrine for Injection Sales Market Share by Application (2027-2032) Table 55. Global Matrine for Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Matrine for Injection Price by Application (2027-2032) & (US$/Unit) Table 57. Chengdu Tiantai Mount Pharmaceutical Company Information Table 58. Chengdu Tiantai Mount Pharmaceutical Business Overview Table 59. Chengdu Tiantai Mount Pharmaceutical Matrine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Chengdu Tiantai Mount Pharmaceutical Matrine for Injection Product Portfolio Table 61. Chengdu Tiantai Mount Pharmaceutical Recent Development Table 62. Henan Rongcheng Pharmaceutical Company Information Table 63. Henan Rongcheng Pharmaceutical Business Overview Table 64. Henan Rongcheng Pharmaceutical Matrine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Henan Rongcheng Pharmaceutical Matrine for Injection Product Portfolio Table 66. Henan Rongcheng Pharmaceutical Recent Development Table 67. Jiuquan Dadeli Pharmaceutical Company Information Table 68. Jiuquan Dadeli Pharmaceutical Business Overview Table 69. Jiuquan Dadeli Pharmaceutical Matrine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Jiuquan Dadeli Pharmaceutical Matrine for Injection Product Portfolio Table 71. Jiuquan Dadeli Pharmaceutical Recent Development Table 72. Nirvana Pharmaceutical Company Information Table 73. Nirvana Pharmaceutical Business Overview Table 74. Nirvana Pharmaceutical Matrine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Nirvana Pharmaceutical Matrine for Injection Product Portfolio Table 76. Nirvana Pharmaceutical Recent Development Table 77. Trifecta Pharma Co. Ltd Company Information Table 78. Trifecta Pharma Co. Ltd Business Overview Table 79. Trifecta Pharma Co. Ltd Matrine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Trifecta Pharma Co. Ltd Matrine for Injection Product Portfolio Table 81. Trifecta Pharma Co. Ltd Recent Development Table 82. CTTQ PHARMA Company Information Table 83. CTTQ PHARMA Business Overview Table 84. CTTQ PHARMA Matrine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. CTTQ PHARMA Matrine for Injection Product Portfolio Table 86. CTTQ PHARMA Recent Development Table 87. North America Matrine for Injection Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Matrine for Injection Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Matrine for Injection Sales by Type (2021-2026) & (K Units) Table 90. North America Matrine for Injection Sales by Type (2027-2032) & (K Units) Table 91. North America Matrine for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 92. North America Matrine for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 93. North America Matrine for Injection Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Matrine for Injection Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Matrine for Injection Sales by Application (2021-2026) & (K Units) Table 96. North America Matrine for Injection Sales by Application (2027-2032) & (K Units) Table 97. North America Matrine for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 98. North America Matrine for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 99. North America Matrine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Matrine for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Matrine for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Matrine for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 103. North America Matrine for Injection Sales by Country (2021-2026) & (K Units) Table 104. North America Matrine for Injection Sales by Country (2027-2032) & (K Units) Table 105. North America Matrine for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 106. North America Matrine for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 107. United States Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 108. Canada Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 109. Europe Matrine for Injection Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Matrine for Injection Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Matrine for Injection Sales by Type (2021-2026) & (K Units) Table 112. Europe Matrine for Injection Sales by Type (2027-2032) & (K Units) Table 113. Europe Matrine for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 114. Europe Matrine for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 115. Europe Matrine for Injection Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Matrine for Injection Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Matrine for Injection Sales by Application (2021-2026) & (K Units) Table 118. Europe Matrine for Injection Sales by Application (2027-2032) & (K Units) Table 119. Europe Matrine for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 120. Europe Matrine for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 121. Europe Matrine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Matrine for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Matrine for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Matrine for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. Europe Matrine for Injection Sales by Country (2021-2026) & (K Units) Table 126. Europe Matrine for Injection Sales by Country (2027-2032) & (K Units) Table 127. Europe Matrine for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 128. Europe Matrine for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 129. Germany Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 130. France Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 131. U.K. Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 132. Italy Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 134. China Matrine for Injection Revenue by Type (2021-2026) & (US$ Million) Table 135. China Matrine for Injection Revenue by Type (2027-2032) & (US$ Million) Table 136. China Matrine for Injection Sales by Type (2021-2026) & (K Units) Table 137. China Matrine for Injection Sales by Type (2027-2032) & (K Units) Table 138. China Matrine for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 139. China Matrine for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 140. China Matrine for Injection Revenue by Application (2021-2026) & (US$ Million) Table 141. China Matrine for Injection Revenue by Application (2027-2032) & (US$ Million) Table 142. China Matrine for Injection Sales by Application (2021-2026) & (K Units) Table 143. China Matrine for Injection Sales by Application (2027-2032) & (K Units) Table 144. China Matrine for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 145. China Matrine for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Matrine for Injection Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Matrine for Injection Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Matrine for Injection Sales by Type (2021-2026) & (K Units) Table 149. Asia Matrine for Injection Sales by Type (2027-2032) & (K Units) Table 150. Asia Matrine for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Asia Matrine for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Asia Matrine for Injection Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Matrine for Injection Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Matrine for Injection Sales by Application (2021-2026) & (K Units) Table 155. Asia Matrine for Injection Sales by Application (2027-2032) & (K Units) Table 156. Asia Matrine for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Asia Matrine for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Matrine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Matrine for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Matrine for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Matrine for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Asia Matrine for Injection Sales by Country (2021-2026) & (K Units) Table 163. Asia Matrine for Injection Sales by Country (2027-2032) & (K Units) Table 164. Asia Matrine for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Asia Matrine for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Japan Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 167. South Korea Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 168. India Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 169. Australia Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 170. China Taiwan Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Matrine for Injection Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Matrine for Injection Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Matrine for Injection Sales by Type (2021-2026) & (K Units) Table 175. SAMEA Matrine for Injection Sales by Type (2027-2032) & (K Units) Table 176. SAMEA Matrine for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 177. SAMEA Matrine for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 178. SAMEA Matrine for Injection Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Matrine for Injection Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Matrine for Injection Sales by Application (2021-2026) & (K Units) Table 181. SAMEA Matrine for Injection Sales by Application (2027-2032) & (K Units) Table 182. SAMEA Matrine for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 183. SAMEA Matrine for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 184. SAMEA Matrine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Matrine for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Matrine for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Matrine for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. SAMEA Matrine for Injection Sales by Country (2021-2026) & (K Units) Table 189. SAMEA Matrine for Injection Sales by Country (2027-2032) & (K Units) Table 190. SAMEA Matrine for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 191. SAMEA Matrine for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Brazil Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 193. Argentina Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 194. Chile Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 195. Colombia Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 196. Peru Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 198. Israel Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 199. UAE Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 200. Turkey Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 201. Iran Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 202. Egypt Matrine for Injection Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Matrine for Injection Distributors List Table 206. Matrine for Injection Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Matrine for Injection Image Figure 2. Global Matrine for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Matrine for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Intramuscular Injection Image Figure 5. Intravenous Drip Image Figure 6. Global Matrine for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Matrine for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Chronic Hepatitis B Treatment Image Figure 9. Tumor Radiotherapy Image Figure 10. Others Image Figure 11. Global Matrine for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Matrine for Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Matrine for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Matrine for Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Matrine for Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Matrine for Injection Sales (2021-2032) & (K Units) Figure 17. Global Matrine for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Matrine for Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Matrine for Injection Sales YoY (2021-2032) & (K Units) Figure 20. Europe Matrine for Injection Sales YoY (2021-2032) & (K Units) Figure 21. China Matrine for Injection Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Matrine for Injection Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Matrine for Injection Sales YoY (2021-2032) & (K Units) Figure 24. Global Matrine for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Matrine for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Matrine for Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Matrine for Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Matrine for Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Matrine for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Matrine for Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Matrine for Injection Sales Market Share by Type (2021-2032) Figure 33. Global Matrine for Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Matrine for Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Matrine for Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Matrine for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Matrine for Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Matrine for Injection Sales Market Share by Application (2021-2032) Figure 39. North America Matrine for Injection Revenue Share by Type (2021-2032) Figure 40. North America Matrine for Injection Sales Share by Type (2021-2032) Figure 41. North America Matrine for Injection Revenue Share by Application (2021-2032) Figure 42. North America Matrine for Injection Sales Share by Application (2021-2032) Figure 43. North America Matrine for Injection Revenue Share by Country (2021-2032) Figure 44. North America Matrine for Injection Sales Share by Country (2021-2032) Figure 45. Europe Matrine for Injection Revenue Share by Type (2021-2032) Figure 46. Europe Matrine for Injection Sales Share by Type (2021-2032) Figure 47. Europe Matrine for Injection Revenue Share by Application (2021-2032) Figure 48. Europe Matrine for Injection Sales Share by Application (2021-2032) Figure 49. Europe Matrine for Injection Revenue Share by Country (2021-2032) Figure 50. Europe Matrine for Injection Sales Share by Country (2021-2032) Figure 51. China Matrine for Injection Revenue Share by Type (2021-2032) Figure 52. China Matrine for Injection Sales Share by Type (2021-2032) Figure 53. China Matrine for Injection Revenue Share by Application (2021-2032) Figure 54. China Matrine for Injection Sales Share by Application (2021-2032) Figure 55. Asia Matrine for Injection Revenue Share by Type (2021-2032) Figure 56. Asia Matrine for Injection Sales Share by Type (2021-2032) Figure 57. Asia Matrine for Injection Revenue Share by Application (2021-2032) Figure 58. Asia Matrine for Injection Sales Share by Application (2021-2032) Figure 59. Asia Matrine for Injection Revenue Share by Country (2021-2032) Figure 60. Asia Matrine for Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Matrine for Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Matrine for Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Matrine for Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Matrine for Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Matrine for Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Matrine for Injection Sales Share by Country (2021-2032) Figure 67. Matrine for Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Matrine for Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Intramuscular Injection
  • Intravenous Drip
Applications
  • Chronic Hepatitis B Treatment
  • Tumor Radiotherapy
  • Others
Companies covered
  • Chengdu Tiantai Mount Pharmaceutical
  • Henan Rongcheng Pharmaceutical
  • Jiuquan Dadeli Pharmaceutical
  • Nirvana Pharmaceutical
  • Trifecta Pharma Co. Ltd
  • CTTQ PHARMA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Matrine for Injection Market by Type
  3. 1.2.1 Global Matrine for Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Intramuscular Injection
  5. 1.2.3 Intravenous Drip
  6. 1.3 Matrine for Injection Market by Application
  7. 1.3.1 Global Matrine for Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Chronic Hepatitis B Treatment
  9. 1.3.3 Tumor Radiotherapy
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Matrine for Injection Market Dynamics
  1. 2.1 Matrine for Injection Industry Trends
  2. 2.2 Matrine for Injection Industry Drivers
  3. 2.3 Matrine for Injection Industry Opportunities and Challenges
  4. 2.4 Matrine for Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Matrine for Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Matrine for Injection Revenue by Region
  3. 3.2.1 Global Matrine for Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Matrine for Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Matrine for Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Matrine for Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Matrine for Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Matrine for Injection Sales by Region
  9. 3.4.1 Global Matrine for Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Matrine for Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Matrine for Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Matrine for Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Matrine for Injection Revenue by Manufacturers
  2. 4.1.1 Global Matrine for Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Matrine for Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Matrine for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Matrine for Injection Sales by Manufacturers
  6. 4.2.1 Global Matrine for Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Matrine for Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Matrine for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Matrine for Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Matrine for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Matrine for Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Matrine for Injection Manufacturers, Product Type & Application
  13. 4.7 Global Matrine for Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Matrine for Injection Market CR5 and HHI
  16. 4.8.2 2025 Matrine for Injection Tier 1, Tier 2, and Tier 3
5 Matrine for Injection Market by Type
  1. 5.1 Global Matrine for Injection Revenue by Type
  2. 5.1.1 Global Matrine for Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Matrine for Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Matrine for Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Matrine for Injection Sales by Type
  6. 5.2.1 Global Matrine for Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Matrine for Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Matrine for Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Matrine for Injection Price by Type
6 Matrine for Injection Market by Application
  1. 6.1 Global Matrine for Injection Revenue by Application
  2. 6.1.1 Global Matrine for Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Matrine for Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Matrine for Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Matrine for Injection Sales by Application
  6. 6.2.1 Global Matrine for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Matrine for Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Matrine for Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Matrine for Injection Price by Application
7 Company Profiles
  1. 7.1 Chengdu Tiantai Mount Pharmaceutical
  2. 7.1.1 Chengdu Tiantai Mount Pharmaceutical Company Information
  3. 7.1.2 Chengdu Tiantai Mount Pharmaceutical Business Overview
  4. 7.1.3 Chengdu Tiantai Mount Pharmaceutical Matrine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chengdu Tiantai Mount Pharmaceutical Matrine for Injection Product Portfolio
  6. 7.1.5 Chengdu Tiantai Mount Pharmaceutical Recent Developments
  7. 7.2 Henan Rongcheng Pharmaceutical
  8. 7.2.1 Henan Rongcheng Pharmaceutical Company Information
  9. 7.2.2 Henan Rongcheng Pharmaceutical Business Overview
  10. 7.2.3 Henan Rongcheng Pharmaceutical Matrine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Henan Rongcheng Pharmaceutical Matrine for Injection Product Portfolio
  12. 7.2.5 Henan Rongcheng Pharmaceutical Recent Developments
  13. 7.3 Jiuquan Dadeli Pharmaceutical
  14. 7.3.1 Jiuquan Dadeli Pharmaceutical Company Information
  15. 7.3.2 Jiuquan Dadeli Pharmaceutical Business Overview
  16. 7.3.3 Jiuquan Dadeli Pharmaceutical Matrine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Jiuquan Dadeli Pharmaceutical Matrine for Injection Product Portfolio
  18. 7.3.5 Jiuquan Dadeli Pharmaceutical Recent Developments
  19. 7.4 Nirvana Pharmaceutical
  20. 7.4.1 Nirvana Pharmaceutical Company Information
  21. 7.4.2 Nirvana Pharmaceutical Business Overview
  22. 7.4.3 Nirvana Pharmaceutical Matrine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Nirvana Pharmaceutical Matrine for Injection Product Portfolio
  24. 7.4.5 Nirvana Pharmaceutical Recent Developments
  25. 7.5 Trifecta Pharma Co. Ltd
  26. 7.5.1 Trifecta Pharma Co. Ltd Company Information
  27. 7.5.2 Trifecta Pharma Co. Ltd Business Overview
  28. 7.5.3 Trifecta Pharma Co. Ltd Matrine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Trifecta Pharma Co. Ltd Matrine for Injection Product Portfolio
  30. 7.5.5 Trifecta Pharma Co. Ltd Recent Developments
  31. 7.6 CTTQ PHARMA
  32. 7.6.1 CTTQ PHARMA Company Information
  33. 7.6.2 CTTQ PHARMA Business Overview
  34. 7.6.3 CTTQ PHARMA Matrine for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 CTTQ PHARMA Matrine for Injection Product Portfolio
  36. 7.6.5 CTTQ PHARMA Recent Developments
8 North America
  1. 8.1 North America Matrine for Injection Market Size by Type
  2. 8.1.1 North America Matrine for Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Matrine for Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Matrine for Injection Price by Type (2021-2032)
  5. 8.2 North America Matrine for Injection Market Size by Application
  6. 8.2.1 North America Matrine for Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Matrine for Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Matrine for Injection Price by Application (2021-2032)
  9. 8.3 North America Matrine for Injection Market Size by Country
  10. 8.3.1 North America Matrine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Matrine for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Matrine for Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Matrine for Injection Market Size by Type
  2. 9.1.1 Europe Matrine for Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Matrine for Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Matrine for Injection Price by Type (2021-2032)
  5. 9.2 Europe Matrine for Injection Market Size by Application
  6. 9.2.1 Europe Matrine for Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Matrine for Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Matrine for Injection Price by Application (2021-2032)
  9. 9.3 Europe Matrine for Injection Market Size by Country
  10. 9.3.1 Europe Matrine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Matrine for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Matrine for Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Matrine for Injection Market Size by Type
  2. 10.1.1 China Matrine for Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Matrine for Injection Sales by Type (2021-2032)
  4. 10.1.3 China Matrine for Injection Price by Type (2021-2032)
  5. 10.2 China Matrine for Injection Market Size by Application
  6. 10.2.1 China Matrine for Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Matrine for Injection Sales by Application (2021-2032)
  8. 10.2.3 China Matrine for Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Matrine for Injection Market Size by Type
  2. 11.1.1 Asia Matrine for Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Matrine for Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Matrine for Injection Price by Type (2021-2032)
  5. 11.2 Asia Matrine for Injection Market Size by Application
  6. 11.2.1 Asia Matrine for Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Matrine for Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Matrine for Injection Price by Application (2021-2032)
  9. 11.3 Asia Matrine for Injection Market Size by Country
  10. 11.3.1 Asia Matrine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Matrine for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Matrine for Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Matrine for Injection Market Size by Type
  2. 12.1.1 SAMEA Matrine for Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Matrine for Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Matrine for Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Matrine for Injection Market Size by Application
  6. 12.2.1 SAMEA Matrine for Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Matrine for Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Matrine for Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Matrine for Injection Market Size by Country
  10. 12.3.1 SAMEA Matrine for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Matrine for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Matrine for Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Matrine for Injection Value Chain Analysis
  2. 13.1.1 Matrine for Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Matrine for Injection Production Mode & Process
  6. 13.2 Matrine for Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Matrine for Injection Distributors
  9. 13.2.3 Matrine for Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst